Sort by
Search results
Factor VIII Deficient Plasma
Measurement of actor VIII (FVIII) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FVIII deficient plasma is required.
Factor VII Deficient Plasma
Measurement of factor VII (FVII / proaccelerin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human FVII deficient plasma is required
CRYOcheck Factor II (Prothrombin) Deficient Plasma, frozen
Deficient substrate for clot-based factor II assays.
CRYOcheck Factor II (Prothrombin) Deficient Plasma, frozen
Deficient substrate for clot-based factor II assays.
Factor II (Prothrombin) Deficient Plasma
Measurement of factor II (FII / prothrombin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human prothrombin deficient plasma is required.
Factor II (Prothrombin) Deficient Plasma
Measurement of Factor II (FII / prothrombin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human prothrombin deficient plasma is required.
(h)PT-Phen (PT reagent, recombinant)
Determination of prothrombin time (PT) in human citrated plasma.
(h)PT-Phen (PT reagent, recombinant)
Determination of prothrombin time (PT) in human citrated plasma.
vWF Deficient Plasma, congenital (Type 2A), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 2A) deficient plasma.
vWF Deficient Plasma, congenital (Type 1), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 1) deficient plasma.